CRISPR, Genomics, and Ayurvedic Rasayana: Convergence in Longevity Science
In June 2026, the first participant was dosed in a Phase 1 trial of ER-100 for open-angle glaucoma and non-arteritic...
Ayurvedic articles on CRISPR
In June 2026, the first participant was dosed in a Phase 1 trial of ER-100 for open-angle glaucoma and non-arteritic...
Ashwagandha generated more clinical trial activity between 2020 and 2025 than any other Ayurvedic herb.